ATE156117T1 - 15-deoxyspergualine-analoge, verfahren in ihrer herstellung und ihre verwendung als immunosuppressiva - Google Patents

15-deoxyspergualine-analoge, verfahren in ihrer herstellung und ihre verwendung als immunosuppressiva

Info

Publication number
ATE156117T1
ATE156117T1 AT94403019T AT94403019T ATE156117T1 AT E156117 T1 ATE156117 T1 AT E156117T1 AT 94403019 T AT94403019 T AT 94403019T AT 94403019 T AT94403019 T AT 94403019T AT E156117 T1 ATE156117 T1 AT E156117T1
Authority
AT
Austria
Prior art keywords
analogues
deoxyspergualine
immunosuppressants
production
addn
Prior art date
Application number
AT94403019T
Other languages
English (en)
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9402125A external-priority patent/FR2716451B1/fr
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Application granted granted Critical
Publication of ATE156117T1 publication Critical patent/ATE156117T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT94403019T 1994-02-24 1994-12-26 15-deoxyspergualine-analoge, verfahren in ihrer herstellung und ihre verwendung als immunosuppressiva ATE156117T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9402125A FR2716451B1 (fr) 1994-02-24 1994-02-24 Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR9406706A FR2716452B1 (fr) 1994-02-24 1994-06-01 Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (1)

Publication Number Publication Date
ATE156117T1 true ATE156117T1 (de) 1997-08-15

Family

ID=26230971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94403019T ATE156117T1 (de) 1994-02-24 1994-12-26 15-deoxyspergualine-analoge, verfahren in ihrer herstellung und ihre verwendung als immunosuppressiva

Country Status (23)

Country Link
US (1) US5637613A (de)
EP (1) EP0669316B1 (de)
JP (1) JP2874839B2 (de)
KR (1) KR100188991B1 (de)
CN (1) CN1148378C (de)
AT (1) ATE156117T1 (de)
AU (1) AU691847B2 (de)
CA (1) CA2143216C (de)
CZ (1) CZ287985B6 (de)
DE (1) DE69404624T2 (de)
DK (1) DK0669316T3 (de)
ES (1) ES2106480T3 (de)
FI (1) FI950728A (de)
FR (1) FR2716452B1 (de)
GR (1) GR3025164T3 (de)
HK (1) HK1000489A1 (de)
HU (1) HUT70958A (de)
NO (1) NO302816B1 (de)
NZ (1) NZ270449A (de)
RU (1) RU2113431C1 (de)
SK (1) SK281058B6 (de)
TW (1) TW317562B (de)
UA (1) UA37217C2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
US5834421A (en) * 1997-02-27 1998-11-10 Genzyme Corporation Methods and compositions for treating cystic fibrosis
US5985824A (en) * 1997-02-27 1999-11-16 Genzyme Corporation Methods and compositions for treating cystic fibrosis
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
MX339759B (es) * 2010-07-29 2016-06-08 Fournier Lab Sa Compuesto para el tratamiento/prevencion de enfermedades inflamatorias oculares.
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤

Also Published As

Publication number Publication date
RU95102479A (ru) 1997-05-10
ES2106480T3 (es) 1997-11-01
NO302816B1 (no) 1998-04-27
FR2716452A1 (fr) 1995-08-25
EP0669316A1 (de) 1995-08-30
JPH0841007A (ja) 1996-02-13
HU9500556D0 (en) 1995-04-28
AU1028895A (en) 1995-08-31
NZ270449A (en) 1996-08-27
DE69404624T2 (de) 1998-02-05
SK281058B6 (sk) 2000-11-07
HUT70958A (en) 1995-11-28
RU2113431C1 (ru) 1998-06-20
FI950728A (fi) 1995-08-25
FI950728A0 (fi) 1995-02-17
EP0669316B1 (de) 1997-07-30
CZ287985B6 (cs) 2001-03-14
KR950032097A (ko) 1995-12-20
CZ50295A3 (en) 1995-10-18
DE69404624D1 (de) 1997-09-04
UA37217C2 (uk) 2001-05-15
CN1148378C (zh) 2004-05-05
CA2143216C (en) 1999-04-13
GR3025164T3 (en) 1998-02-27
NO950664D0 (no) 1995-02-22
DK0669316T3 (da) 1998-03-09
HK1000489A1 (en) 1998-03-27
FR2716452B1 (fr) 1996-05-10
SK24795A3 (en) 1995-09-13
AU691847B2 (en) 1998-05-28
US5637613A (en) 1997-06-10
CA2143216A1 (en) 1995-08-25
NO950664L (no) 1995-08-25
KR100188991B1 (ko) 1999-06-01
JP2874839B2 (ja) 1999-03-24
TW317562B (de) 1997-10-11
CN1119191A (zh) 1996-03-27

Similar Documents

Publication Publication Date Title
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
ZA842185B (en) New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof
WO1999024022A3 (en) Isoquinoline derivatives for treating disorders associated with 5ht7 receptors
ATE156117T1 (de) 15-deoxyspergualine-analoge, verfahren in ihrer herstellung und ihre verwendung als immunosuppressiva
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
TW340109B (en) Amide derivatives and their therapeutic use
UA39920C2 (uk) Аналоги 15-дезоксиспергуаліну або їх солі, що мають імуносупресивну активність, спосіб їх отримання та фармацевтична композиція на їх основі
DE69903053D1 (de) Diaminocyclobuten-3,4-dionderivate, deren herstellung und deren verwendung
DE69500409T2 (de) Herstellung von 3-Isothiazolen
EP0201354A3 (en) 2,4-diphenyl-1,3-dioxanes
DE3770359D1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
FI861951A0 (fi) 1,3-oxatianderivat.
DE69131444T2 (de) Optisch aktive 1,4-Dihydropyridinderivate sowie Verfahren zu ihrer Herstellung
ATE24487T1 (de) Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE205189T1 (de) Benzolsulfonylamin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69211773T2 (de) Amidderivate von 1-Amino-Octahydropyrido[2,1-c][1,4]oxazin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
CO4950545A1 (es) 3-piperidinoles y 3-piperidinonas sustituidos teniendo actividad inhibidora de proteasas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee